| Phase 3, Open/Label Study to evaluate the safety and efficacy of TMC 435 plus Pegylated Interferon alfa-2a and Ripavirin administrated for 12 weeks in treatment-naïve Subjects with Chronic genotype 1 or genotype 4 HCV infection |
Completed |
TMC435 (simeprevir) |
3b |
TMC435HPC3014 |
KFSH & RC-R |
| An Open-Label, Multinational, Multicenter, Phase IIIB Study With Subcutaneus Administration Of Trastuzumab In Patient With Her2-Positive Early Breast Cancer To Evaluate Patient Satisfaction |
Terminated |
Trastuzumab SC |
3b |
ML28851 |
KKUH (Closed) |
| An Open-label, Multicentre, Randomised, 2-arm Study to Investigate the Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose Versus Oral Iron for the Treatment of Iron Deficiency Anaemia in Pregnant Women |
Terminated |
Ferrous Sulphate + Ferinject |
3 |
FER-ASAP-2009-01 |
KFSH & RC-R |
| A RANDOMIZED, PARTIALLY-BLIND, PLACEBO-CONTROLLED, PILOT, DOSE-RANGING STUDY TO ASSESS THE EFFECT OF GWP42003 ON LIVER FAT LEVELS IN SUBJECT WITH FATTY LIVER DISEASE |
Rejected |
Cannabidiol |
2a |
GWZMD1188 |
KKUH |
| A Phase III, Multicenter, Randomized, Open-Lable Clinical Trial Comparing the Efficacy and Safety of MK-0431 A (the Fixed-Dose Combination of Sitagliptin and Metformin) to That of Liraglutide in Patients With Type 2 Diabetes Mellitus |
Terminated |
MK-0431A (Sitagliptin / Metformin) vs Liraglutide |
3 |
MK-0431A-180-00 |
KKUH |
| A Multinational, Randomised, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Ticagrelor Twice Daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Stroke in Patients With Type 2 Diabetes Mellitus (THEMIS - Effect of Ticagrelor on Health Outcomes in diabEtes Mellitus Patients Intervention Study) |
Ongoing |
Ticagrelor |
3b |
D513BC00001 |
King Khalid University Hospital (Riyadh) |
| An Open Label, Randomised Phase III Trial of BIBW 2992 and Vinorelbine Versus Trastuzumab and Vinorelbine in Patients With Metastatic HER2-overexpressing Breast Cancer Failing One Prior Trastuzumab Treatment |
Completed |
BIBW 2992+ Vinorelbine VS.Trastuzumab |
3 |
1200.75 |
KFMC |
| A Phase III randomized, double-blind, placebo-controlled study of LEE011 or placebo in combination with tamoxifen and goserelin or a non-steroidal aromatase inhibitor (NSAI) and goserelin for the treatment of premenopausal women with hormone receptor positive, HER2-negative, advanced breast cancer |
Ongoing |
LEE011 (Ribociclib) |
3 |
CLEE011E2301 |
KKUH |
| A multi-center open-label parallel group randomized controlled trial to compare iGlarLixi versus premixed insulin in patients with type 2 diabetes who have failed to achieve glycemic control with basal insulin and oral antidiabetic agents |
Ongoing |
HOE901 (insulin glargine)/ AVE0010 (lixisenatide) combination |
IIIb |
LPS15017 |
KFMC |
| Use of high dose of Colistin in Multidrug Resistant Gram Negative infections. Randomized Controlled clinical Trial |
Completed |
Colistin |
4 |
KSMC-12-13 |
King Saud Medical City |
